Hilliard Lyons Upgrades Meridian Biosciences (VIVO) to Buy
Tweet
Share
E-mailGet Alerts VIVO Hot Sheet
Price: $4.07 +0.25%
Rating Summary:
3 Buy, 4 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 36
Rating Summary:
3 Buy, 4 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 36
Join SI Premium – FREE
Hilliard Lyons upgraded Meridian Biosciences (NASDAQ: VIVO) from Neutral to Buy with a price target of $22.00.
For an analyst ratings summary and ratings history on Meridian Biosciences click here. For more ratings news on Meridian Biosciences click here.
Shares of Meridian Biosciences closed at $19.56 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Upgrades DNB ASA (DNB:NO) (DNHBY) to Equalweight
- Piper Sandler Upgrades Capricor Therapeutics (CAPR) to Overweight
- Morgan Stanley Upgrades Robinhood Markets (HOOD) to Overweight
Create E-mail Alert Related Categories
UpgradesRelated Entities
Hilliard LyonsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
